Life extension technology: Implications for public policy and regulation

References

• Barinaga, M. (2001) ‘Life extension: Our salvation or our ruin?’ Science of Aging Knowledge Environment (SAGE KE) doi: 10.1126/sageke.2001.1.ns1.
   Google Scholar
• Beaubien, G. (1994) ‘Why get old?’ Chicago Tribune (Tempo section), October 20, pp. 1, 13.
   Google Scholar
• Bishop, P.J. and Davis, G.C. (2002) ‘Mapping public participation in policy choices’ Australian Journal of Public Administration 61(1):14–29.
   Google Scholar
• Burstein, P. (2003) ‘The impact of public opinion on public policy: A review and an agenda’ Political Research Quarterly 56(1):29–40.
   Google Scholar
• Cutas, D.E. (2008) ‘Life extension, overpopulation and the right to life: Against lethal ethics’ Journal of Medical Ethics 34:1–3.
   Google Scholar
• Davis, J.K. (2005) ‘Life-extension and the Malthusian objection’ Journal of Medicine and Philosophy 30:27–44.
   Google Scholar
• de Grey, A.D.N.J. (2004) ‘Escape velocity: Why the prospect of extreme human life extension matters now’ PLoS Biology 2(6):723–726.
   Google Scholar
• de Grey, A.D.N.J.; Baynes, J.W.; Berd, D.; Heward, C. B.; Pawalec, G. and Stock, G. (2002) ‘Is human aging still mysterious enough to be left only to scientists?’ BioEssays 24:667–676.
   Google Scholar
• Dietrich, H. and Schibeci, R. (2003) ‘Beyond public perceptions of gene technology: Community participation in public policy in Australia’ Public Understanding of Science 12(4):381–401.
   Google Scholar
• Fukuyama, F. (2002) Our Posthuman Future: Consequences of the Biotechnology Revolution Farrar, Strauss and Giroux: New York.
   Google Scholar
• Harris, J. (2004) ‘Immortal ethics’ Annals of the New York Academy of Sciences 1019: 527–534.
   Google Scholar
• Hayflick, L. (2001) ‘Anti-aging medicine: Hype, hope, and reality’ Generations 25(4):20–26.
   Google Scholar
• Holden, C. (2002) ‘The quest to reverse time’s toll’ Science 295:1032–1033.
   Google Scholar
• Ipsos MORI (2006) ‘Three score years and … when?’ BUPA Health Debate, 22 September 2006. Available at www.ipsos-mori.com/polls/2006/bupa/shtml [Date of access 7.02.07].
   Google Scholar
• Juengst, E.T.; Binstock, R.H.; Mehlman, M.; Post, S.G. and Whitehouse, P. (2003) ‘Biogerontology, ‘anti-aging medicine’, and the challenges of human enhancement’ Hastings Center Report 33:21–30.
   Google Scholar
• Kass, L.R. (2002) Life, Liberty and the Defense of Dignity: The Challenge for Bioethics Encounter Books: San Francisco, CA.
   Google Scholar
• Louria, D.B. (2005) ‘Extraordinary longevity: Individual and societal issues’ Journal of the American Geriatrics Society 53:s317–s319.
   Google Scholar
• Lucke, J.C.; Ryan, B. and Hall, W. (2006) ‘What does the community think about lifespan extension technologies? The need for an empirical base for ethical and policy debates’ Australasian Journal on Ageing 25:180–184.
   Google Scholar
• Mehlman, M.J.; Binstock, R.H.; Juengst, E.T.; Ponsaran, R.S. and Whitehouse, P.J. (2004) ‘Anti-aging medicine: Can consumers be better protected?’ Gerontologist 44:304–310.
   Google Scholar
• Moody, H.R. (2001/2002) ‘Who’s afraid of life extension?’ Generations 25:33–37.
   Google Scholar
• Olshansky, S.J.; Hayflick, L. and Carnes, B.A. (2002) ‘No truth to the fountain of youth’ Scientific American 286:92–95.
   Google Scholar
• Perls, T.T. (2004) ‘Anti-aging quackery: Human growth hormone and tricks of the trade’ Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 59:682–691.
   Google Scholar
• Prime Minister’s Science, Engineering and Innovation Council (PMSEIC) (2003) Promoting Healthy Ageing in Australia Department of Education, Science and Training: Canberra, ACT.
   Google Scholar
• Reisman, N.R. (2004) ‘Legal issues associated with the current and future practice of anti-aging medicine’ Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 59:674–681.
   Google Scholar
• Richel, T. (2003) ‘Will human life expectancy quadruple in the next hundred years? Sixty gerontologists say public debate of life extension is necessary’ Journal of Anti-Aging Medicine 6:309–314.
   Google Scholar
• Ring, A.L. (2002) ‘Using ‘anti-ageing’ to market cosmetic surgery: Just good business, or another wrinkle on the face of medical practice?’ Medical Journal of Australia 176(12):597–599.
   Google Scholar
• Schibeci, R.; Harwood, J. and Dietrich, H. (2006) ‘Community involvement in biotechnology policy?’ Science Communication 27(3): 429–445.
   Google Scholar
• Solomon, L.D. (2006) The Quest for Human Longevity: Science, Business, and Public Policy Transaction Publishers: New Brunswick, NJ.
   Google Scholar
• Stock, G.B. (2004) ‘The pitfalls of planning for demographic change’ Annals of the New York Academy of Sciences 1019:546–551.
   Google Scholar
• Underwood M.; Bartlett, H. and Hall, W. (2007) ‘Community attitudes to the regulation of life extension’ Annals of the New York Academy of Sciences 1114:288–299.
   Google Scholar
• Underwood, M.; Bartlett, H. and Hall, W. (2009a) ‘Professional and personal attitudes of researchers in aging towards life extension’ Biogerontology 10(1):73–81.
   Google Scholar
• Underwood, M.; Bartlett, H.; Partridge, B.; Lucke, J. and Hall, W. (2009b) ‘Community perceptions on the significant extension of life: An exploratory study among urban adults in Brisbane, Australia’ Social Science and Medicine 68:496–503.
   Google Scholar
• World Health Organization (2002) ‘Current practices and controversies in assisted reproduction’ in Vayena, E.; Rowe, P. and Griffin, P. (eds) Report of a Meeting on ‘Medical, Ethical and Social Aspects of Assisted Reproduction’ 17–21 September 2001 WHO: Geneva.
   Google Scholar